Literature DB >> 15517434

Computerized movement analysis and beta-CIT-SPECT in patients with restless legs syndrome.

M Mrowka1, M Jöbges, G Berding, N Schimke, M Shing, P Odin.   

Abstract

Considering the positive effect of dopaminergic treatment on Restless Legs Syndrome (RLS), it has been suggested that the cause of RLS may be linked to central dopaminergic dysfunction. As problems of alternating movements can result from a failure in the dopaminergic system, we used a movement analysis system to analyse this and in-parallel, performed [123I]beta-CIT-SPECT to investigate signs of dopaminergic dysfunction in patients with RLS. In 10 patients with idiopathic RLS, we conducted a three-dimensional computerized ultrasound-based movement analysis before a single dose of levodopa (L-dopa) was given and 90 minutes after the L-dopa challenge. In 6 of the 10 RLS patients, the striatal dopamine transporter system was studied with [123I]beta-CIT-SPECT. We did not observe any significant change in the movement pattern with the computerized movement analysis and no significant effect of L-dopa on the movement. We did not detect any significant differences between patients and normal controls regarding beta-CIT-signals in putamen or caudate nucleus, respectively. There was, however, a slight but significant change regarding the relative [123I]beta-CIT-SPECT binding in the putamen vs. the caudate nucleus. We conclude that the methods used could not detect any definite signs of changed central dopaminergic function in patients with RLS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517434     DOI: 10.1007/s00702-004-0217-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  9 in total

1.  The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome.

Authors:  Christopher J Earley; Hiroto Kuwabara; Dean F Wong; Charlene Gamaldo; Rachel Salas; James Brasic; Hayden T Ravert; Robert F Dannals; Richard P Allen
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

Review 2.  Imaging brain functional and metabolic changes in restless legs syndrome.

Authors:  Giovanni Rizzo; Caterina Tonon; David Manners; Claudia Testa; Raffaele Lodi
Journal:  Curr Neurol Neurosci Rep       Date:  2013-09       Impact factor: 5.081

Review 3.  Brain imaging and networks in restless legs syndrome.

Authors:  Giovanni Rizzo; Xu Li; Sebastiano Galantucci; Massimo Filippi; Yong Won Cho
Journal:  Sleep Med       Date:  2016-08-29       Impact factor: 3.492

Review 4.  Brain-iron deficiency models of restless legs syndrome.

Authors:  Christopher J Earley; Byron C Jones; Sergi Ferré
Journal:  Exp Neurol       Date:  2022-06-30       Impact factor: 5.620

Review 5.  Restless legs syndrome: pathophysiology, diagnosis and treatment.

Authors:  Pankaj Satija; William G Ondo
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.

Authors:  James R Connor; Xin-Sheng Wang; Richard P Allen; John L Beard; Jason A Wiesinger; Barbara T Felt; Christopher J Earley
Journal:  Brain       Date:  2009-05-25       Impact factor: 13.501

7.  The effect of selenium administration on restless leg syndrome treatment.

Authors:  A G Rahimdel; P Ayatollahi; A Zeinali; N Mehrabanian; A Mellat-Ardekani
Journal:  Iran Red Crescent Med J       Date:  2012-01-01       Impact factor: 0.611

Review 8.  Restless Legs Syndrome and Leg Motor Restlessness in Parkinson's Disease.

Authors:  Keisuke Suzuki; Masayuki Miyamoto; Tomoyuki Miyamoto; Koichi Hirata
Journal:  Parkinsons Dis       Date:  2015-10-04

9.  The Neurochemistry of Autism.

Authors:  Rosa Marotta; Maria C Risoleo; Giovanni Messina; Lucia Parisi; Marco Carotenuto; Luigi Vetri; Michele Roccella
Journal:  Brain Sci       Date:  2020-03-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.